Skip to main content

Table 1 Patient baseline features

From: Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin

VariablePatients enrolled (n = 152)
Age, mean ± SD (years)42.8 ± 13.7
Gender (female/male)70/82
Body mass index, mean ± SD (kg/m2)23.1 ± 2.8
Cigarette smoking (yes/no)24/128
Alcohol drinking (yes/no)28/124
Allergy to penicillin (skin test positive/past allergy history)112/40
Diagnosis (PUD/NUD/UID)14/63/75
H. pylori density (+/++/+++) a30/28/19
Amoxicillin resistance (%) b3.1
Cefuroxime resistance (%) b4.6
Clarithromycin resistance (%) b38.5
Metronidazole resistance (%) b63.1
Levofloxacin resistance (%) b40.0
Tetracycline resistance (%) b6.2
  1. NUD Non-ulcer dyspepsia, PUD Peptic ulcer disease, UID Uninvestigated dyspepsia
  2. aData for H. pylori density were available in 77 patients
  3. bData for H. pylori antibacterial sensitivity were available in 65 patients